Patents by Inventor Nicole Westerfeld

Nicole Westerfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
    Patent number: 8367077
    Abstract: The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes according to the invention. Further, the present invention relates to uses and methods involving said virosomes, as well as to a method for preparing same.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: February 5, 2013
    Assignee: Pevion Biotech, AG
    Inventors: Rinaldo Zurbriggen, Christian Moser, Andreas Kammer, Mario Amacker, Nicole Westerfeld, Silvia Rasi
  • Virosomes Comprising Hemagglutinin Derived from an Influenza Virus Produced in a Cell Line, Compositions, Methods of Manufacturing, Use Thereof
    Publication number: 20110045057
    Abstract: The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes according to the invention. Further, the present invention relates to uses and methods involving said virosomes, as well as to a method for preparing same.
    Type: Application
    Filed: June 13, 2008
    Publication date: February 24, 2011
    Inventors: Rinaldo Zurbriggen, Christian Moser, Silvia Rasi, Andreas Kammer, Mario Amacker, Nicole Westerfeld
  • Recombinant mva strains as potential vaccines against p. falciparum malaria
    Publication number: 20060127413
    Abstract: This invention relates to recombinant viruses based on MVA, which comprise at least one nucleic acid coding for a Plasmodium falciparum MSP-1 protein, a fragment or mutein of it. Furthermore, methods for the production of the recombinant viruses, virus-containing vaccines and the use of the recombinant viruses for the prophylaxis and/or therapy of malaria are provided.
    Type: Application
    Filed: September 26, 2003
    Publication date: June 15, 2006
    Inventors: Gerd Sutter, Hermann Bujard, Nicole Westerfeld, Miao Jun